longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Protalix Biotherap(PLX.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Transcript: Protalix BioTherapeutics Q1 2026 Earnings Conference Call

benzinga_article·05/13/2026 20:19
US
PLX
+2.63%
US
PBE
+0.89%
US
XBI
+2.89%
benzinga_article·05/13/2026 20:19
US
PLX
+2.63%
US
PBE
+0.89%
US
XBI
+2.89%

Protalix Biotherap | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 33.75 M

Earnings Watch·05/13/2026 18:59
US
PLX
+2.63%
Earnings Watch·05/13/2026 18:59
US
PLX
+2.63%

Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results | PLX Stock News

StockTitan·05/13/2026 10:50
US
PLX
+2.63%
US
IHE
+1.02%
US
VHT
+0.30%
StockTitan·05/13/2026 10:50
US
PLX
+2.63%
US
IHE
+1.02%
US
VHT
+0.30%

Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026 | PLX Stock News

StockTitan·05/06/2026 10:50
US
PLX
+2.63%
US
XBI
+2.89%
US
IBBQ
+1.83%
StockTitan·05/06/2026 10:50
US
PLX
+2.63%
US
XBI
+2.89%
US
IBBQ
+1.83%
© 2026 Longbridge|Disclaimer

Event Tracking

May13
Protalix Biotherap released FY2026 Q1 earnings on May 13 Pre-Market (EST), actual revenue USD 33.75 M (forecast USD 11.47 M), actual EPS USD 0.2199 (forecast USD -0.01)
13:30
May6
Protalix Biotherap to Release FY2026 Q1 Earnings on May 13 Pre-Market EST, Forecast Revenue USD 11.47 M, EPS USD -0.01
00:12
Mar18
Protalix Biotherap released FY2025 earnings on March 18 During-Market (EST), actual revenue USD 52.74 M (forecast USD 57.98 M), actual EPS USD -0.084 (forecast USD -0.005)
20:00
Protalix Biotherap released FY2025 Q4 earnings on March 18 During-Market EST: Actual Revenue USD 9.122M (Forecast USD 14.36M), Actual EPS USD -0.0692 (Forecast USD 0.005)
20:00
Mar11
Protalix Biotherap to Release FY2025 Earnings on March 18 During-Market EST, Forecast Revenue USD 57.98 M, EPS USD -0.005
00:07
Dec17
Protalix Secures Exclusive License to Develop Rare Kidney Disease Drugs with Secarna
12:12

Schedules & Filings

Schedules
Filings
May13
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 33.75 M, Net Income 18.32 M, EPS 0.2199

Mar18
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 9.122 M, Net Income -5.504 M, EPS -0.0692

Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 17.85 M, Net Income 2.355 M, EPS 0.0297

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
OPTH
5.850
+2,387.24%
+5.615
HCWB
2.890
+172.63%
+1.840
FSHPR
0.1666
+105.43%
+0.086
MWC
9.210
+95.13%
+4.500
SLXN
0.5018
+86.54%
+0.231
GCL
0.7341
+70.05%
+0.303
EMISR
0.1593
+59.14%
+0.059
CELG.RT
0.1579
+46.20%
+0.050
PETZ
1.160
+43.21%
+0.350
AMPGZ
0.8296
+43.03%
+0.250
View More